Applying the Use of Novel Biomarkers for Neuroendocrine Tumors in the Clinic: Where Are We Now?

International Journal of Endocrine Oncology
doi 10.2217/ije-2017-0012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Where Are We Now?

Veterinary Record
MedicineVeterinary
2014English

The New Handshake: Where We Are Now

International Journal on Online Dispute Resolution
2016English

Digitalis: Where Are We Now?

Heart
Cardiovascular MedicineCardiology
1985English

Understanding Diabetic Teratogenesis: Where Are We Now and Where Are We Going?

Birth Defects Research Part A - Clinical and Molecular Teratology
Child HealthPediatricsPerinatologyMedicineDevelopmental BiologyEmbryology
2010English

Liver Transplantation Today: Where We Are Now and Where We Are Going

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Cytologic-Histologic Correlation: Where Are We Now, and Where Are We Going?

Cancer cytopathology
Cancer ResearchOncology
2018English

Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?

The American Journal of Geriatric Pharmacotherapy
2009English

Ischemic Nephropathy: Where Are We Now?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

Debating the Use of Social Media in Higher Education in Australasia: Where Are We Now?

Australasian Journal of Educational Technology
E-learningEducation
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy